The Cancer Letter

Inside information on cancer research and drug development

The Hutch, University of Washington, and Seattle Children’s forming a more streamlined union

In Brief

UM Greenebaum receives Comprehensive Cancer Center renewal from NCI
Olufunmilayo I. Olopade receives 2021 William L. McGuire Memorial Lecture Award from SABCS
NCI names recipients of Cancer Clinical Investigator Team Leadership Awards
Marco Argenti, Karyn Temple named to PanCAN board; Margaret Tempero named chair of Scientific and Medical Advisory Board
PanCAN awards $3 million in grants
University of Minnesota establishes Institute for Global Cancer Prevention Research

Drugs & Targets

Darzalex Faspro + pomalidomide and dexamethasone receives FDA approval for multiple myeloma
Padcev receives regular approval from FDA for locally advanced or metastatic urothelial cancer
Merck will withdraw Keytruda’s “dangling” indication for gastric cancer
Keytruda receives FDA approval for cSCC indication
Rylaze receives FDA approval as component of chemotherapy regimen for leukemia and lymphoma
EC approves Opdivo + Yervoy for adults in dMMR or MSI-H metastatic colorectal cancer indication

In The Clinic

Trials & Tribulations

Rogue drug maker first inflates the price of lomustine, then says No to Medicare coverage

Rogue drug maker first inflates the price of lomustine, then says No to Medicare coverage
Annals of Unintended Consequences: How FDA regulations undermine the biosimilar marketplace and the BPCIA
Trials & Tribulations
Precision oncology must evolve to address health disparities
FreeTrials & Tribulations
It’s time to rethink clinical trials in a post-pandemic world
Trials & Tribulations
Best practices in preventing heartbreak:
Trials & Tribulations

Latest Issue

Read the latest issue
DOWNLOAD THE PDF

UPCOMING EVENTS

Jul 2021
29
Panel discussion: The National Cancer Act at 50 and the cancer centers that set the model for a nation
View All Events

The Cancer Letter is an independent weekly news publication and the leading source for information on the issues that shape oncology.

Login

Looking for IP Login?